JP2023529089A5 - - Google Patents
Info
- Publication number
- JP2023529089A5 JP2023529089A5 JP2022573437A JP2022573437A JP2023529089A5 JP 2023529089 A5 JP2023529089 A5 JP 2023529089A5 JP 2022573437 A JP2022573437 A JP 2022573437A JP 2022573437 A JP2022573437 A JP 2022573437A JP 2023529089 A5 JP2023529089 A5 JP 2023529089A5
- Authority
- JP
- Japan
- Prior art keywords
- trem
- seq
- subject
- inhibitor
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20305603.1 | 2020-06-05 | ||
| EP20305603 | 2020-06-05 | ||
| PCT/EP2021/065194 WO2021245291A1 (en) | 2020-06-05 | 2021-06-07 | Trem-1 inhibitor for use in the treatment of a subject suffering from a coronavirus infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023529089A JP2023529089A (ja) | 2023-07-07 |
| JP2023529089A5 true JP2023529089A5 (https=) | 2024-06-14 |
Family
ID=71614781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022573437A Pending JP2023529089A (ja) | 2020-06-05 | 2021-06-07 | コロナウイルス感染症に罹患した対象の治療に使用するためのｔｒｅｍ－１阻害剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230201301A1 (https=) |
| EP (1) | EP4161551A1 (https=) |
| JP (1) | JP2023529089A (https=) |
| CN (1) | CN116490199A (https=) |
| CA (1) | CA3180293A1 (https=) |
| WO (1) | WO2021245291A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060084082A1 (en) | 1997-03-07 | 2006-04-20 | Human Genome Sciences, Inc. | 186 human secreted proteins |
| US8981061B2 (en) | 2001-03-20 | 2015-03-17 | Novo Nordisk A/S | Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof |
| LT2555789T (lt) * | 2010-04-08 | 2020-09-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Inhibuojantys peptidai, kilę iš trem tipo transkripto 1 (tlt-1), ir jų naudojimas |
| US9550830B2 (en) | 2012-02-15 | 2017-01-24 | Novo Nordisk A/S | Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1) |
| JP6411218B2 (ja) | 2012-02-15 | 2018-10-24 | ノヴォ ノルディスク アー／エス | 骨髄細胞で発現されるトリガー受容体１（ｔｒｅｍ−１）に結合し、それを遮断する抗体 |
| AU2013311606B2 (en) * | 2012-09-07 | 2017-10-05 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (TREM-1) Trem-Like Transcript 1 (TLT-1) and uses thereof |
| US10765679B2 (en) * | 2015-07-04 | 2020-09-08 | Emory University | Use of TREM-1 inhibitors for treatment, elimination and eradication of HIV-1 infection |
| US20210364532A1 (en) * | 2018-09-28 | 2021-11-25 | Inotrem | Use of soluble trem-1 levels for identifying subjects susceptible to respond to an anti-inflammatory therapy |
-
2021
- 2021-06-07 JP JP2022573437A patent/JP2023529089A/ja active Pending
- 2021-06-07 CA CA3180293A patent/CA3180293A1/en active Pending
- 2021-06-07 EP EP21731962.3A patent/EP4161551A1/en active Pending
- 2021-06-07 WO PCT/EP2021/065194 patent/WO2021245291A1/en not_active Ceased
- 2021-06-07 US US18/008,245 patent/US20230201301A1/en active Pending
- 2021-06-07 CN CN202180057069.6A patent/CN116490199A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ye et al. | ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway | |
| Wen et al. | Acetylbritannilactone modulates microRNA-155-mediated inflammatory response in ischemic cerebral tissues | |
| Navarrete et al. | Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy | |
| Smith et al. | The impact of regional astrocyte interferon-γ signaling during chronic autoimmunity: a novel role for the immunoproteasome | |
| Saiz et al. | Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity | |
| Giunti et al. | The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells | |
| US20170298352A1 (en) | Compositions and methods for treating hepatic fibrosis | |
| CN111655267B (zh) | 预防或治疗鼻病毒感染的药物 | |
| US20170007618A1 (en) | Serotonin 2c receptor antagonists to prevent and treat stress-related trauma disorders | |
| Xu et al. | Effects of early hemofiltration on organ function and intra-abdominal pressure in severe acute pancreatitis patients with abdominal compartment syndrome | |
| JP2018523696A (ja) | 肝疾患および状態を治療する方法および組成物 | |
| Hirao et al. | Recombinant human soluble thrombomodulin prevents acute lung injury in a rat cardiopulmonary bypass model | |
| Deng et al. | Cardiopulmonary Bypass Induces Acute Lung Injury via the High‐Mobility Group Box 1/Toll‐Like Receptor 4 Pathway | |
| KR20220097463A (ko) | 바이러스 분자 수준을 감소시키는 방법 | |
| Gao et al. | Silencing circPalm2 inhibits sepsis-induced acute lung injury by sponging miR-376b-3p and targeting MAP3K1 | |
| Zhang et al. | Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl4-induced cirrhotic rats | |
| Wang et al. | High-mobility group box 1 protein is involved in the protective effect of Saquinavir on ventilation-induced lung injury in mice | |
| JP2023529089A5 (https=) | ||
| CN116509874A (zh) | 甲基巴多索隆在制备改善病毒性心肌炎或病毒性心肌损伤的药物中的用途 | |
| Nickel et al. | Estrogen suppresses cardiac IL-6 after trauma-hemorrhage via a hypoxia-inducible factor 1α-mediated pathway | |
| US20230002770A1 (en) | Il-34 antisense agents and methods of using same | |
| JP2023549500A5 (https=) | ||
| US8569374B2 (en) | NADPH oxidase inhibition pharmacotherapies for obstructive sleep apnea syndrome and its associated morbidities | |
| CN118178657A (zh) | 以klf13为上调或激活靶标的物质在制备用于改善肌肉萎缩的药物中的应用 | |
| US20210301006A1 (en) | Methods of treating acute respiratory distress syndrome |